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Abstract It has been a common practice among the
oncologist to reduce the dosage of adjuvant radiotherapy
for patients after free jejunal Xap reconstruction. The
current aims to study potential risk of radiation to the
visceral  Xap and the subsequent oncological outcome.
Between 1996 and 2010, consecutive patients with
carcinoma of the hypopharynx requiring laryngectomy,
circumferential pharyngectomy and post-operative
irradiation were recruited. Ninety-six patients were
recruited. TNM tumor staging at presentation was: stage
II (40.6%), stage III (34.4%) and stage IV (25.0%).
Median follow-up period after surgery was 68 months.
After tumor ablation, reconstruction was performed
using free jejunal Xap (60.4%), pectoralis major myocu-
taneous (PM) Xap (31.3%) and free anterolateral thigh
(ALT)  Xap (8.3%). All patients underwent adjuvant
radiotherapy within 6.4 weeks after surgery. The mean
total dose of radiation given to those receiving cutaneous
and jejunal Xap reconstruction was 62.2 Gy and 54.8 Gy,
respectively. There was no secondary ischaemia or
necrosis of the Xaps after radiotherapy. The 5-year actu-
arial loco-regional tumor control for the cutaneous Xap
and jejunal Xap group was: stage II (61 vs. 69%, p =0 . 9 ) ,
stage III (36 vs. 46%, p = 0.2) and stage IV (32 vs. 14%,
p = 0.04), respectively. Reduction of radiation dosage in
free jejunal group adversely aVects the oncological con-
trol in stage IV hypopharyngeal carcinoma. In such cir-
cumstances, tubed cutaneous Xaps are the preferred
reconstructive option, so that full-dose radiotherapy can
be given.
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Introduction
Defects created after circumferential pharyngectomy poses
special challenges to reconstructive surgeons. The segment
of upper digestive tract between the oropharynx and esoph-
agus is lost, and the conduit has to be restored for the pas-
sage of food during future swallowing.
Various options of reconstruction are available, with
variable outcomes and complications as published in the
literature. According to our recently published experi-
ence, reconstruction using the free jejunal Xap resulted in
the lowest early post-operative pharyngocutaneous Wstula
rate as well as signiWcantly lower risk of long-term
anastomotic stricture and higher chance of resumption of
normal diet after surgery, when compared with recon-
struction using cutaneous Xaps such as the tubed pecto-
ralis major (PM) Xap or the free anterolateral thigh (ALT)
Xap [1]. Post-operative adjuvant radiotherapy was indi-
cated in the majority of the patients. However, radiation
doses greater than 45 Gy are generally considered to be
above the tolerance of the small bowel, whereas the eVec-
tive dose range for post-operative radiotherapy for squa-
mous cell carcinoma of the head and neck region is
between 57 and 63 Gy [2]. This retrospective study aims
to compare the outcomes of patients having jejunal Xap
and those with cutaneous Xap reconstruction with regard
to post-radiotherapy complications, loco-regional tumor
control as well as survival.
J. Y. W. Chan (&) · V. L. Y. Chow · R. C. L. Chan · G. I. S. K. Lau
Division of Head and Neck Surgery, Department of Surgery, 
Queen Mary Hospital, University of Hong Kong Li Ka Shing 
Faculty of Medicine, 102 Pokfulam Road, Hong Kong SAR, China
e-mail: chanjyw@gmail.com1828 Eur Arch Otorhinolaryngol (2012) 269:1827–1832
123
Patients and methods
From January 1996 and December 2010, at Division of
Head and Neck Surgery, Department of Surgery, The Uni-
versity of Hong Kong at the Queen Mary Hospital, we had
treated 96 patients with advanced tumors at the hypophar-
ynx. Those with history of previous radiotherapy to the
neck were excluded.
All patients have pre-operative work-up for tumor stag-
ing, anesthetic assessment and nutritional build-up if neces-
sary. Subsequently, they underwent total laryngectomy and
circumferential pharyngectomy for tumor extirpation. Cer-
vical lymph node dissection was carried out if there was
lymphatic metastasis. Intra-operative frozen section exami-
nation of the resection margins was performed to ensure
microscopic clearance of disease.
The resultant circumferential pharyngeal defect between
the oropharynx above and the esophagus below was recon-
structed with either the cutaneous Xaps [pectoralis major
(PM) Xap and free anterolateral thigh (ALT) Xap] or the
free jejunal Xap. The choice of the reconstructive methods
depended on surgeons’ preference as well as patients’ fac-
tors such as medical co-morbidities, donor site availability
and the presence of suitable recipient blood vessels in the
neck to support microvascular free tissue transfer. The sur-
gical techniques of the respective reconstructive options
were described in detail in previous publications [3–16].
Essentially, for cutaneous Xap reconstruction, the rectangu-
lar skin island of the PM or ALT Xap was designed and
fashioned into a tube to replace the upper digestive tract
that had been resected with the tumor (Fig. 1). For visceral
Xap reconstruction, the segment of the jejunum supplied by
the second arcade of vessels was harvested and used
(Fig. 2). All patients received nasogastric tube feeding for
nutritional support during early post-operative period. Gas-
trograYn swallow study was performed 1 week after sur-
gery to ensure satisfactory wound healing before
commencing oral feeding. Regular endoscopic examination
was performed to check the perfusion status of the Xaps.
Those patients with signiWcant delay of post-operative
adjuvant chemoradiotherapy secondary to anastomotic
leakage or necrotic Xap requiring multiple surgeries were
excluded. All patients were referred to clinical oncologists
for post-operative adjuvant chemoradiotherapy.
External beam radiotherapy was commenced as soon as
possible after all the surgical wounds were healed. Radia-
tion was delivered by Cobalt 60, 4MV, or 6MV linear
accelerator, which was given once per day with daily frac-
tion size of 2 Gy, 5 days per week. The spinal cord was
shielded after 4,500 cGy and the Xap for the pharyngeal
reconstruction was included in the high-dose Weld of radia-
tion.
Fig. 1 Above, left A trapezoid skin island of the anterolateral thigh
Xap was designed, which was subsequently folded upon itself to form
a tube for anastomosis between the oropharynx above and the cervical
esophagus below. The semi-circular extension of the skin island is used
to resurface the posterior wall of the oropharynx and the nasopharynx,
which was also resected in this patient. Above, right The anastomosis
with the esophagus was completed Wrst in order to immobilize the Xap
for microvascular anastomosis. Below, left Further suturing of the Xap,
which was progressively fashioned into a tube. Nasogastric tube was
inserted for post-operative feeding. Below, right The inset of the Xap is
completed after anastomosing to the oropharynxEur Arch Otorhinolaryngol (2012) 269:1827–1832 1829
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Patients were followed-up regularly with clinical, endo-
scopic and magnetic resonance imaging (MRI) examina-
tions. The data forming the basis of the current study were
collected prospectively. The demographic data of these
patients, the dose of adjuvant radiotherapy given for
patients with diVerent types of reconstruction, the incidence
of complications such as anastomotic leakage and bowel
perforation were analyzed. A stage-to-stage comparison of
the loco-regional tumor control was performed between
diVerent methods of reconstruction. Statistical package for
social science (SPSS v. 17) was used to the analysis of the
data. A p value <0.05 was regarded as statistically signiW-
cant.
Results
We have treated 96 patients during the study period, among
which, 83 were males and 13 were females. The age at pre-
sentation ranged from 32 to 86 years, with a median age of
68 years. The median follow-up period was 68 months
(range 5–174 months). Majority (n = 72, 75.0%) of them
have the primary tumor arising from the hypopharynx. The
rest of the patients have recurrent tumors at the neopharynx
after previous laryngectomy for carcinoma of the larynx
(n = 24, 25.0%). The TNM staging on presentation was
stage II in 39 (40.6%) patients, stage III in 33 (34.4%)
patients and stage IV in 24 (25.0%) patients.
Circumferential resection of the pharynx was performed
for all patients. In the majority (83.3%) of the patients, we
were able to achieve microscopically clear resection mar-
gins. In the rest of the patients, the surgical margins were
either close (n = 12, 12.5%) or involved by dysplasia or
carcinoma in situ (n = 4, 4.2%), as conWrmed by the histo-
logical examination of the paraYn section of the resected
specimen. Selective neck dissection (level II–IV) was per-
formed in 72 sides of the neck, and microscopic lymph
node metastasis was found in 14 (19.4%) occasions. Radi-
cal neck dissection or modiWed radical neck dissection was
performed in 58 sides of the neck. None of the patients had
macroscopic residual tumor after surgery. There was no
signiWcant diVerence in the distribution of R0 or R1 resec-
tion among patients with diVerent stages of disease.
After tumor ablation, 58 (60.4%) patients received free
jejunal Xap reconstruction of the circumferential pharyn-
gectomy defect. The mean length of the jejunal Xap har-
vested was 12.6 cm. The remaining patients had the defects
reconstructed using cutaneous Xaps, either the tubed PM
Xap (n = 30, 31.3%) or tubed free ALT Xap (n =8 ,  8 . 3 % ) .
There was no hospital mortality. The mean time between
operation and the start of radiotherapy was 6.4 weeks. All
patients completed the course of post-operative radiother-
apy, and 67.7% of them had concomitant chemotherapy
given as well. The mean total dose of external radiotherapy
given was 62.2 Gy for patients with cutaneous Xap recon-
struction and 54.8 Gy for those with free jejunal Xap recon-
struction.
Majority (n = 84, 87.5%) of the patients were able to
resume oral feeding during early post-operative period
before the commencement of radiotherapy. Among them,
12 patients had temporary impairment of swallowing due to
the development of mucositis during radiotherapy, and
nasogastric was reinserted for nutritional support. All
patients eventually restored eating per orally within
Fig. 2 Above, left The segment 
of the jejunum supplied by the 
second arcade of blood vessels 
was chosen. The vascular anat-
omy of the bowel was clearly 
visualized with light shining 
from behind. Above, right 
Meticulous dissection of the vas-
cular arcade and the pedicle of 
the Xap from the mesentery were 
then performed. Below, left The 
required length of the jejunum 
was harvested with the supply-
ing vascular arcade, which was 
ready to be transferred to the 
neck for inset. Below, right 
Upon completion of Xap inset. 
Note that the jejunum should be 
position in an isoperistaltic 
direction to facilitate future 
swallowing. Furthermore, 
redundancy of the Xap should be 
avoided to prevent dysphagia1830 Eur Arch Otorhinolaryngol (2012) 269:1827–1832
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2 months upon completion of radiotherapy and none of
them require prolonged nasogastric tube or gastrostomy
feeding. There was no radiation induced salivary leakage or
Xap necrosis. On long-term follow-up, symptomatic stric-
ture formation requiring regular endoscopic dilatation
occurred in 8 (26.7%) patients with tube PM Xap, 1
(12.5%) patient with tubed ALT Xap and 1 (1.7%) patients
with free jejunum Xap reconstruction.
Table 1 showed the stage-to-stage comparison of the 5-
year actuarial loco-regional tumor control between the two
groups of patients receiving cutaneous Xap and jejunal Xap
reconstruction. There was no signiWcant diVerence in loco-
regional tumor control between the two groups for stage II
(61 vs. 69%, p = 0.9) and III (36 vs. 46%, p = 0.2) disease
using diVerent methods of reconstruction. However, the
diVerence became statistically signiWcant in stage IV (32
vs. 14%, p = 0.04) disease. The overall survival for our
patients was 64, 46 and 38% for stage II, III and IV cancer,
respectively. Majority of the patients died of regional
(n = 12) and systemic metastasis (n = 23), while the rest of
them died from metachronous tumor (carcinoma of the
lung, n = 6; carcinoma of the oral cavity, n = 2) or other
unrelated causes (n =4 ) .
Discussion
The management of malignant neoplasms of the hypophar-
ynx remains a therapeutic challenge to the head and neck
surgeons despite advances in surgical techniques and che-
moradiotherapy. Although organ-preserving chemoradio-
therapy has gained increasing popularity over primary
surgical treatment for early stage disease [17, 18], surgery
remains the preferred therapeutic option for locally
advanced disease. It is also the only option for salvage of
failures after chemo-radiotherapy. Because of the high like-
lihood of microscopic residual disease despite radical sur-
gery [19], post-operative radiotherapy is generally
indicated. Evidence shows that adjuvant radiotherapy sig-
niWcantly improved loco-regional control as well as sur-
vival after surgery [20–24] for carcinoma at the
hypopharyngeal region.
Ablative surgery inevitably creates a disruption of the
upper digestive tract, and this is especially true when the
location and extent of tumor necessitates circumferential
removal of the oropharynx and the hypopharynx. Proper
choice of reconstructive techniques is crucial so that the
patients can achieve a better functional outcome. However,
the voluminous literature publications of diVerent options
reXect the complex nature as well as the rapid evolution in
concept and techniques. Our experience shows that free
jejunal transfer is safe and reliable with a high success rate,
and at the same time, the donor site morbidity is minimal at
experienced hands. When compared with tubed PM Xap
and tubed ALT Xap, the incidence of early Wstula (4.6 vs.
23.9 vs. 16.5%, respectively) and late stricture formation
(2.3 vs. 27.2 vs. 12.5%, respectively) is signiWcantly lower
[1]. More than 60% of the patients who received free jeju-
nal Xap reconstruction were able to resume normal, solid
diet eventually. Therefore, in the selected group of suitable
patients, the free jejunal Xap appears to be the ideal choice
for the reconstruction of circumferential pharyngeal
defects.
The jejunum is a radiosensitive organ in its native site in
the abdomen. Radiation injury to the gastrointestinal tract is
well recognized in patients with pelvic or colorectal malig-
nancies who received external beam irradiation up to 60 Gy
[25–27]. Acute functional changes include diarrhea, bloat-
ing and abdominal pain, and reported late sequelae include
chronic diarrhea, malabsorption with steatorrhoea, abdomi-
nal spasms, intestinal obstruction, bleeding and Wstula for-
mation [28]. Radiation enteritis is the main pathological
Wnding, particularly involving the intermitotic cells of the
small intestine [29, 30], leading to sloughing of the epithe-
lium, submucosal Wbrosis, loss of glands, villous atrophy
and ulceration. It is observed that, apart from the total dose
of radiation delivered, the volume of the small intestine
exposed to the radiation is also important in determining
the severity of the presenting symptoms of the patients.
Because of these observations, there has been general-
ized worry among surgeons and oncologists that similar
radiation induced injury can occur to a segment of the jeju-
num transferred to the neck as a free Xap after tumor extir-
pation, leading to potential risk of bowel ischaemia and
necrosis. Investigation in dogs demonstrated reduced
amplitude of peristalsis of the jejunal autografts as well as
stricture formation after exposure to 55 Gy-equivalent dose
of radiation [31]. Histological examinations of the endo-
scopic biopsy specimens of the jejunal Xap in human sub-
jects showed blunting and atrophy of the villi, Wbrosis of
the mucosal lamina propria and round-cell inWltration [32].
Similarly, in our previous study, we have demonstrated
mucosal edema and extensive blunting of jejunal villi at the
completion of radiotherapy [33]. Scanning electron micro-
scopic examination revealed patchy loss of microvilli on
completion and at 1 month after radiotherapy, but these fea-
tures were transient. These histological sequelae after
Table 1 The 5-year actuarial loco-regional tumour control rate
Cutaneous Xap 
reconstruction (%)
Free jejunal Xap 
reconstruction (%)
p value
Stage II 61 69 0.9
Stage III 36 46 0.2
Stage IV 32 14 0.04Eur Arch Otorhinolaryngol (2012) 269:1827–1832 1831
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radiotherapy, however, do not necessarily translate into
clinical consequences. Early data showed no obvious early
or late complications related to the jejunal autograft after
exposure to 57.6–63 Gy of radiation [34]. Other studies
also echo these Wndings by showing no Xap necrosis and
satisfactory swallowing in the majority of the patients after
a mean radiation dose of 59 Gy [35, 36]. It seems like that
high-dose radiation therapy delivered to the jejunal Xap in
the neck is safer than similar radiation given to the jejunum
in its native site. As mentioned before, this may be
explained by the fact that the volume of the bowel irradi-
ated is much smaller in the neck. Moreover, serving simply
as a conduit rather than the organ for absorption of digested
material, the function of the jejunal Xap in the neck is
diVerent from that of the gastrointestinal tract inside the
abdomen.
Nevertheless, its has been a common practice among the
clinical oncologists to reduce the radiation dosage for
patients who had received free jejunal Xap reconstruction in
order to prevent radiation induced complications related to
the jejunal autograft. In our current study, data from the
past 15 years showed that the mean radiation dosage given
to patients after visceral Xap transfer was much lower than
those after cutaneous Xap reconstruction (54.8 vs. 62.2 Gy).
At this level of radiation, there was no secondary ischaemia
or necrosis of the Xap. Despite of the reduction of radiation
dosage in the jejunal group, the diVerence in the 5-year
actuarial loco-regional tumor control between the two
groups of patients was not signiWcant for TNM stage II and
III diseases. However, for stage IV disease, patients with
jejunal  Xap reconstruction had signiWcantly poorer loco-
regional tumor control. This may be explained by the fail-
ure of the reduced dose of radiation to deal with the more
widespread microscopic tumor deposits in the advanced
stage of disease. Despite of the apparently better functional
outcome using the jejunal Xap as demonstrated in our
recent study, the choice of reconstructive options should
never compromise the oncological control. Further large-
scale study is necessary to investigate the safety of high-
dose external beam radiation on the visceral Xap. The sur-
geons should also communicate with the oncologists, and if
a reduced dose of radiation is to be given, then jejunal
transfer should not be the Wrst choice of reconstruction in
advanced staged carcinoma of the hypopharyngeal region.
Conclusions
The loco-regional tumor control is adversely aVected by the
reduction of post-operative adjuvant radiation dosage in
patients with stage IV carcinoma of the hypopharynx
reconstructed using free jejunal Xap after tumor extirpation.
Therefore, tubed cutaneous Xaps, which allow full-dose
radiation to be given, should be the reconstructive option of
choice in such circumstances.
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